Stocks closed higher but off their best levels after two Fed officials dampened speculation the central bank was ready to consider "tapering" its bond-buying.» Read More
April 17- Medical device maker St. Jude Medical Inc said on Wednesday first-quarter profit rose as lower expenses outweighed a decline in sales but warned that full-year revenue will be hurt by foreign exchange effects.
March 27- A U.S. government watchdog has issued a warning about the risk for fraud when doctors buy an ownership interest in a medical device distributor and then share in its profits from sales to hospitals.
WASHINGTON, March 24- Eight months before President Barack Obama's health care law goes prime time, a confederation of industry and business groups is ramping up its lobbying apparatus for an 11th- hour assault on the web of new taxes and regulations.
March 10- A drug-coated heart stent from Japan's Terumo Corp with a dissolving polymer proved just as effective as Abbott Laboratories' top-selling Xience stent at preventing a second procedure to clear the artery, a large study found.
*Europe revisits rules after breast, hip implant scandals. LONDON, Feb 20- One year on from a breast implant scandal that shook confidence in Europe's light-touch system for regulating medical devices, lawmakers and manufacturers are at loggerheads on ways to protect patients from shoddy products.
Feb 19- Medtronic Inc reported higher quarterly earnings on Tuesday, but sales of key heart and spine devices fell and overall European sales weakened in January, sending the company's shares down nearly 3 percent. Chief Financial Officer Gary Ellis attributed the decline in Medtronic's stock to management's comments about Europe.
Feb 19- Medtronic Inc reported higher quarterly earnings on Tuesday, but sales of key products used in heart and spinal procedures missed expectations, sending its shares down more than 3 percent.
U.S. stock index futures rose Tuesday, after the S&P 500 posted its seventh-straight week higher, lifted by optimism for more corporate deals as investors returned from the long Presidents Day holiday weekend.
Feb 19- Medtronic Inc on Tuesday reported higher quarterly earnings as sales rose slightly. Medtronic said its net earnings increased to $988 million, or 97 cents per diluted share, in the third quarter ended on Jan. 25 from $935 million, or 88 cents per diluted share, a year earlier.
Some of the names on the move ahead of the open.
Feb 19- Medtronic Inc on Tuesday reported higher quarterly earnings as sales rose slightly. The maker of implantable heart devices, insulin pumps and products used for spine surgery said its net earnings increased to $988 million, or 97 cents per share, in the third quarter ended on Jan. 25 from $935 million, or 89 cents per share, in the year-earlier period.
*Q4 profit of 90 cents excluding items tops analysts' 77 cents view. Feb 4- Edwards Lifesciences Corp on Monday posted fourth-quarter earnings that beat analyst expectations on strong sales of its replacement heart valve that is implanted in a less-invasive procedure than open-heart surgery.
*Expects 2013 EPS of $3.68- $3.73 vs est $3.62. Jan 23- St. Jude Medical Inc forecast 2013 earnings above market estimates after reporting a better-than-expected fourth-quarter profit as it cut costs, and the company's shares initially fell in early trading Wednesday, but had trimmed losses by midday.
*Expects 2013 EPS of $3.68- $3.73 vs est $3.62. Jan 23- St. Jude Medical Inc forecast 2013 earnings above market estimates after reporting a better-than-expected fourth-quarter profit as it cut costs, but the medical device maker's shares dipped amid skepticism that its markets would improve significantly.
Medtronic expects 2013 earnings, excluding charges, of $3.66 to $3.70 a share, compared with its previous forecast of $3.62 to $3.70 a share.
It’s time for the Lightning Round. Cramer makes the call on viewer favorites.
Check out companies that are making moving after the bell Thursday:
From auto sales to health care to the NFL to the price of gasoline, CNBC's anchors, reporters, editors and contributors make calls on what 2013 will bring.
How everyone will deal with the effects of Obamacare in 2013.
Oct 25- Medical device maker Medtronic Inc edited health journal articles and paid doctors millions of dollars for company-sponsored studies of its Infuse bone-grafting product used in spinal surgery, according to a U.S. Senate report published on Thursday.